Covestor’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Buy
+16
New +$1.18K ﹤0.01% 2129
2026
Q1
– Sell
-4
Closed – – 2534
2025
Q4
$0 Hold
4
– – ﹤0.01% 2506
2025
Q3
$0 Sell
4
-8
-67% -$260 ﹤0.01% 2523
2025
Q2
$0 Sell
12
-6
-33% -$153 ﹤0.01% 2478
2025
Q1
$0 Buy
18
+5
+38% +$103 ﹤0.01% 2480
2024
Q4
$0 Buy
13
+2
+18% +$46 ﹤0.01% 2488
2024
Q3
$0 Buy
+11
New +$268 ﹤0.01% 2472
2024
Q2
– Sell
-24
Closed – – 2491
2024
Q1
$0 Sell
24
-29
-55% -$566 ﹤0.01% 2490
2023
Q4
$1K Sell
53
-63
-54% -$1.04K ﹤0.01% 1991
2023
Q3
$2K Sell
116
-44
-28% -$741 ﹤0.01% 1828
2023
Q2
$2K Buy
+160
New +$2.14K ﹤0.01% 1842

Other funds holding KNSA

Covestor's KNSA Position: Q3 2026 in Review

Covestor opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 16 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2129 among its holdings. This is a return to the name: Covestor previously reported a position in KNSA as recently as Q4 2025.

Covestor first reported a position in KNSA in Q2 2023 and has held it in 11 quarters since. The position peaked at $2K in Q3 2023. 226 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Covestor held 16 shares of Kiniksa Pharmaceuticals worth $1K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new Covestor position in Q3 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2129 holding.
  • Covestor first reported a position in Kiniksa Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
  • Covestor's Kiniksa Pharmaceuticals position peaked at $2K in Q3 2023.
  • 226 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.